Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

SX Gu, T Tyagi, K Jain, VW Gu, SH Lee… - Nature Reviews …, 2021 - nature.com
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …

Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review

V Balbirsingh, AS Mohammed, AM Turner… - Thorax, 2022 - thorax.bmj.com
Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of
cardiovascular disease (CVD) and concomitant disease leads to reduced quality of life …

[HTML][HTML] Platelets in chronic obstructive pulmonary disease: an update on pathophysiology and implications for antiplatelet therapy

H Mallah, S Ball, J Sekhon, K Parmar, K Nugent - Respiratory medicine, 2020 - Elsevier
Platelets are essential mediators of inflammation and thrombosis. Chronic obstructive
pulmonary disease (COPD) is a heterogeneous multisystem disease, causing significant …

Incidence of acute cardiovascular event after acute exacerbation of COPD

T Goto, YJ Shimada, MK Faridi, CA Camargo… - Journal of general …, 2018 - Springer
Background There is a lack of comprehensive view of the association between acute
exacerbation of COPD (AECOPD) and the risk of acute cardiovascular events. Objective To …

Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy

A Papaporfyriou, K Bartziokas, D Gompelmann… - Life, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of
mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only …

Impact of comorbidities and commonly used drugs on mortality in COPD–real-world data from a primary care setting

J Ellingsen, G Johansson, K Larsson… - … journal of chronic …, 2020 - Taylor & Francis
Background Life expectancy is significantly shorter for patients with chronic obstructive
pulmonary disease (COPD) than the general population. Concurrent diseases are known to …

Extrapulmonary comorbidities associated with chronic obstructive pulmonary disease: A review

Y Xiang, X Luo - … Journal of Chronic Obstructive Pulmonary Disease, 2024 - Taylor & Francis
Most patients with chronic obstructive pulmonary disease (COPD) suffer from at least one
additional, clinically relevant chronic disease. To a degree, the high global prevalence and …

Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: A cohort study

SY Yu, MSM Ip, X Li, KS Cheung, QW Ren… - PLoS …, 2022 - journals.plos.org
Background Evidence suggests that chronic obstructive pulmonary disease (COPD) is
associated with a higher risk of lung carcinoma. Using a territory-wide clinical electronic …

Aspirin use and respiratory morbidity in COPD: a propensity score-matched analysis in subpopulations and intermediate outcome measures in COPD study

A Fawzy, N Putcha, CP Aaron, RP Bowler… - Chest, 2019 - Elsevier
Background Aspirin use in COPD has been associated with reduced all-cause mortality in
meta-regression analysis with few equivocal studies. However, the effect of aspirin on COPD …

Inflammation as the nexus: exploring the link between acute myocardial infarction and chronic obstructive pulmonary disease

E Marriott, A Singanayagam… - Frontiers in cardiovascular …, 2024 - frontiersin.org
Chronic obstructive pulmonary disease (COPD), particularly following acute exacerbations
(AE-COPD), significantly heightens the risks and mortality associated with acute myocardial …